OPGN Kapitalisasi Akuntansi OpGen

OpGen, Inc. (OPGN) develops rapid pathogen analysis systems that enable the prompt selection of therapies for patients in intensive care units. This daily price chart on the GURU.Markets platform, where the metric stands at -0.08, complements data regarding AI platform developments and rapid DNA tests for epidemiology. However, the business is constrained by a shortage of funds and a complex debt restructuring process for its European divisions under the supervision of turnaround managers.
Rincian metrik lan analitis perusahaan OpGen (OPGN)

Amid asset liquidations and the collapse of commercial platforms, OpGen, Inc. (OPGN) has lost its competitive advantages, making the analysis of residual capital critical. Book capitalization, which measures the sum of net assets minus all liabilities, allows investors to track the real value of the business via the book capitalization profile on GURU.Markets, separating the fundamental trend from market noise during the issuer's period of insolvency.